Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05970679
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Who this might be right for
Hypercholesterolemia, Dyslipidemia
Daewon Pharmaceutical Co., Ltd. 252
Early research (Phase 1)Study completedNCT06923956
What this trial is testing

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Who this might be right for
HypercholesterolaemiaMixed DyslipidaemiaCardiovascular Diseases
Humanis Saglık Anonim Sirketi 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07391722
What this trial is testing

DNV001 Injection in Patients With Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Hangzhou Dinovate Biotech Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT00093899
What this trial is testing

Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Who this might be right for
HyperlipidemiaHypercholesterolemiaHypertriglyceridemia
Organon and Co 611
Large-scale testing (Phase 3)Active Not RecruitingNCT07473960
What this trial is testing

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Innovent Biologics (Suzhou) Co. Ltd. 198
Post-approval studies (Phase 4)Study completedNCT00754039
What this trial is testing

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

Who this might be right for
HypercholesterolemiaHyperlipidemia, Familial Combined
Daiichi Sankyo 129
Not applicableActive Not RecruitingNCT04579367
What this trial is testing

Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 5,000
Large-scale testing (Phase 3)Looking for participantsNCT07614958
What this trial is testing

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

Who this might be right for
Mixed DyslipidemiaHypercholesterolaemia
A. Menarini International Licensing S.A. 426
Large-scale testing (Phase 3)Study completedNCT00136799
What this trial is testing

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Who this might be right for
Mixed DyslipidemiaHypercholesterolemia
Novartis 325
Large-scale testing (Phase 3)Study completedNCT02833844
What this trial is testing

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Amgen 467
Large-scale testing (Phase 3)Study completedNCT05255458
What this trial is testing

Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 122
Large-scale testing (Phase 3)Study completedNCT05532800
What this trial is testing

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 255
Large-scale testing (Phase 3)Study completedNCT05255094
What this trial is testing

Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 464
Large-scale testing (Phase 3)Ended earlyNCT03433755
What this trial is testing

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 259
Large-scale testing (Phase 3)Study completedNCT01420549
What this trial is testing

Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Ache Laboratorios Farmaceuticos S.A. 129
Large-scale testing (Phase 3)Ended earlyNCT01274559
What this trial is testing

Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,173
Large-scale testing (Phase 3)Study completedNCT00376584
What this trial is testing

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Who this might be right for
HypercholesteremiaHyperlipidemia
Merck Sharp & Dohme LLC 825
Large-scale testing (Phase 3)Study completedNCT01953328
What this trial is testing

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Who this might be right for
Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
Amgen 409
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750341
What this trial is testing

Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 156
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Next Page